Skandinaviska Enskilda Banken (SEB)
TXG icon

Skandinaviska Enskilda Banken (SEB)’s 10x Genomics TXG Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,156
Closed -$925K – 1074
2022
Q1 		$925K Sell
12,156
-100
-0.8% -$8.75K 0.01% 761
2021
Q4 		$1.85M Sell
12,256
-74,529
-86% -$11.4M 0.01% 664
2021
Q3 		$12.6M Hold
86,785
– – 0.07% 249
2021
Q2 		$17M Buy
86,785
+77,685
+854% +$14.1M 0.1% 193
2021
Q1 		$1.65M Hold
9,100
– – 0.01% 714
2020
Q4 		$1.29M Buy
+9,100
New +$1.32M 0.01% 765

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s TXG Position: Q2 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 12,156 shares — an estimated $925K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in TXG in Q4 2020 and held it in 6 quarters. The position peaked at $17M in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 12,156 10x Genomics shares in Q2 2022, an estimated $925K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in 10x Genomics in Q4 2020 and held it in 6 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s 10x Genomics position peaked at $17M in Q2 2021.
  • 254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2022, filed 10 Aug 2022.